Q97834505
motion by Fredrik Olovsson 2008
Press Enter · cited answer in seconds
0 sources
Q97834505
Summary
Q97834505 is an individual motion[1].
Key Facts
- Q97834505 authored Fredrik Olovsson[2].
- Q97834505's instance of is recorded as individual motion[3].
- Q97834505's part of the series is recorded as motions of the 2008-2009 legislative session of the Riksdag[4].
- Q97834505's language of work or name is recorded as Swedish[5].
- Q97834505's publication date is recorded as +2008-09-29T00:00:00Z[6].
- Q97834505's main subject is recorded as medication[7].
- Q97834505's work available at URL is recorded as http://data.riksdagen.se/dokument/GW02So325[8].
- Q97834505's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GW02So325[9].
- Q97834505's applies to jurisdiction is recorded as Sweden[10].
- Q97834505's legal citation of this text is recorded as Mot. 2008/09:So325[11].
- Q97834505's title is recorded as Skärpta regler för marknadsföring av läkemedel[12].
- Q97834505's maintained by WikiProject is recorded as Project Riksdagen's documents[13].
- Q97834505's copyright status is recorded as public domain[14].
- Q97834505's legislative committee is recorded as Committee on Health and Welfare[15].
- Q97834505's Swedish Riksdag document ID is recorded as GW02So325[16].
Body
Works and Contributions
Q97834505 authored Fredrik Olovsson[2].